Literature DB >> 16339646

Keynote address: The challenge of thalassemia for the developing countries.

David J Weatherall1.   

Abstract

The thalassemias occur at some of their highest frequencies in the developing countries, particularly those of Asia. In many countries, facilities for the control of these conditions are extremely limited. Although a great deal can be done to help the situation by developing further North-South and South-South partnerships for disseminating better practice, the major problem for the future lies in the unwillingness of governments and international health agencies to accept that the thalassemias present a health burden comparable to that of other major diseases in the developing countries. However, preliminary analyses suggest that, at least in the case of Asia, this is not true. Further work of this nature, together with more detailed frequency and economic data, are required to provide solid evidence for the health burden posed by thalassemia in the developing world. Unless this is done, the large populations of patients with thalassemia in these countries will continue to be neglected.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339646     DOI: 10.1196/annals.1345.002

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  Assessing Parental Knowledge About Thalassemia in a Thalassemia Center of Karachi, Pakistan.

Authors:  Humaira Maheen; Farrukh Malik; Barera Siddique; Asim Qidwai
Journal:  J Genet Couns       Date:  2015-04-07       Impact factor: 2.537

2.  [Identification of a new 3.8kb deletional α thalassemia and detection of the deletion fragment].

Authors:  Ge Huang; You-Wei Zheng; Jing-Jian Wang; Ji Wu; Sheng-Nan Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

Review 3.  Cure for thalassemia major - from allogeneic hematopoietic stem cell transplantation to gene therapy.

Authors:  Alok Srivastava; Ramachandran V Shaji
Journal:  Haematologica       Date:  2016-12-01       Impact factor: 9.941

Review 4.  Management of non-transfusion-dependent thalassemia: a practical guide.

Authors:  Ali T Taher; Maria Domenica Cappellini
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

5.  HLA-matched sibling bone marrow transplantation for β-thalassemia major.

Authors:  Mitchell Sabloff; Mammen Chandy; Zhiwei Wang; Brent R Logan; Ardeshir Ghavamzadeh; Chi-Kong Li; Syed Mohammad Irfan; Christopher N Bredeson; Morton J Cowan; Robert Peter Gale; Gregory A Hale; John Horan; Suradej Hongeng; Mary Eapen; Mark C Walters
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

6.  Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children.

Authors:  Arthorn Riewpaiboon; Issarang Nuchprayoon; Kitti Torcharus; Kaemthong Indaratna; Montarat Thavorncharoensap; Bang-On Ubol
Journal:  BMC Res Notes       Date:  2010-01-30

7.  Socio-demographic Profile and Economic Burden of Treatment of Transfusion Dependent Thalassemia.

Authors:  Amita Moirangthem; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2017-11-09       Impact factor: 1.967

Review 8.  Past, present & future scenario of thalassaemic care & control in India.

Authors:  Ishwar C Verma; Renu Saxena; Sudha Kohli
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

9.  Radix Astragali Stimulates p38 MARK Phosphorylation in Pediatric Patients with β-Thalassemia.

Authors:  Zhuoming Lu; Xinhua Qian; Chunhong Zhang; Zhiwen Chen; Guangliang Du
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-02       Impact factor: 2.629

10.  The prevalence and molecular spectrum of α- and β-globin gene mutations in 14,332 families of Guangdong Province, China.

Authors:  Aihua Yin; Bing Li; Mingyong Luo; Longchang Xu; Li Wu; Liang Zhang; Yuanzhu Ma; Tingting Chen; Shuang Gao; Juqing Liang; Hao Guo; Danqing Qin; Jicheng Wang; Tenglong Yuan; Yixia Wang; Wei-wei Huang; Wen-Fei He; Yanxia Zhang; Chang Liu; Sujian Xia; Qingshan Chen; Qingguo Zhao; Xiaozhuang Zhang
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.